Sales Veränderung Datum
Acadia Pharmaceuticals USD 231.04M 19.34M 2023-12
ALKERMES USD 377.48M 3.46M 2023-12
Alnylam Pharmaceuticals USD 439.72M 310.81M 2023-12
Biogen USD 2.39B 144M 2023-12
BioMarin Pharmaceutical USD 646.21M 64.88M 2023-12
Bristol-Myers Squibb USD 11.48B 511M 2023-12
Cara Therapeutics USD 3M 1.86M 2023-12
Corcept Therapeutics USD 135.4M 11.8M 2023-12
Cytokinetics USD 1.67M 1.29M 2023-12
Eisai JPY 177.7B 1.09B 2023-12
Eli Lilly USD 9.35B 145.2M 2023-12
Incyte USD 1.01B 94.32M 2023-12
Intra Cellular Therapies USD 132.1M 5.93M 2023-12
J&J USD 21.4B 44M 2023-12
Marinus Pharmaceuticals USD 7.19M 148K 2023-12
Moderna USD 2.81B 980M 2023-12
Neurocrine Biosciences USD 515.2M 16.4M 2023-12
Pfizer USD 14.25B 1.02B 2023-12
Prothena USD 316K 84.55M 2023-12
PTC Therapeutics USD 307.06M 110.48M 2023-12
Sarepta Therapeutics USD 396.78M 64.96M 2023-12
Ultragenyx Pharmaceutical USD 127.39M 29.34M 2023-12
Vanda Pharmaceuticals USD 45.27M 6.46M 2023-12
Vertex Pharmaceuticals USD 2.52B 34.2M 2023-12



Acadia Pharmaceuticals Der Umsatz - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Mar 2024.